Diabetes, Vol 46, Issue 11 1829-1839, Copyright © 1997 by American Diabetes Association

ARTICLES

Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

We investigated familial clustering of diabetic retinopathy and nephropathy in the families of 372 subjects from the Diabetes Control and Complications Trial (DCCT). These subjects had 467 first-degree relatives with IDDM or NIDDM. Family sizes ranged from two to six. A complete data set was obtained from 241 relatives of 217 DCCT subjects. Among the DCCT subjects, 53% were in the intensive treatment group and 47% were in the conventional group; 44% were from the primary prevention cohort (no retinopathy or microalbuminuria at the DCCT baseline) and 56% were from the secondary intervention cohort (mild-to-moderate nonproliferative retinopathy and <200 mg/24 h albumin excretion rate [AER] at baseline). Retinopathy and nephropathy were assessed with seven-field stereo fundus photography and timed urinary AER measurements. Retinopathy was assessed using the Early Treatment Diabetic Retinopathy Study (ETDRS) scale. ETDRS scores and AERs were adjusted for the DCCT treatment group and for significant covariates from among sex, age, diabetes duration, HbA1c value, and body weight. Familial associations were assessed by comparing the prevalence of retinopathy and nephropathy in diabetic relatives of the respective positive versus negative DCCT subjects. To determine family clustering of the severity of retinopathy or nephropathy, the intraclass (familial) correlation was computed from the log-adjusted retinopathy and nephropathy scores of DCCT subjects and their relatives for all family members and sib-sib relationships. For parent-offspring, mother-child, and father-child relationships, the pairwise estimate of the correlations was computed. A correlation of 0.2 was considered to be biologically meaningful a priori. Among families of patients in the intensive and conventional groups combined, there was an increased risk of severe retinopathy (an ETDRS score > or =47, clinically significant macular edema, or laser treatment in either eye) among relatives of retinopathy-positive vs. retinopathy-negative DCCT subjects in the secondary intervention cohort (odds ratio [OR], 3.1; 95% CI 1.2-7.8; P < 0.05). There was no increase in the risk of retinopathy of any severity (microaneurysms or worse) in the relatives of retinopathy-positive vs. retinopathy-negative DCCT subjects of the primary prevention cohort. There was an increased risk of nephropathy (AER >40 mg/24 h) in relatives of nephropathy-positive versus nephropathy-negative DCCT subjects of the secondary intervention cohort (OR, 5.4; 95% CI 2.2-13.7; P < 0.001). The risk of severe retinopathy in the relatives of positive versus negative subjects from the conventional treatment group alone (OR, 4.3; 95% CI 1.01-18.6; P < 0.05) was statistically significant and somewhat greater than that among relatives of the subjects in intensive treatment group (OR, 2.4; 95% CI 0.7-8.1), which was not significant. Correlations for the severity of retinopathy were 0.187 (all family members), 0.327 (parent-offspring), 0.249 (father-child), 0.391 (mother-child), and 0.060 (sib-sib), using the combined treatment group families. All these correlations were statistically significant (P < 0.05), except for sib-sib. The results showed similar trends when the families from the conventional and intensive treatment groups were analyzed separately. Correlations for nephropathy in the combined treatment group families were 0.063 (all family members), 0.138 (parent-offspring), 0.170 (father-child), 0.103 (mother-child), and 0.107 (sib-sib). None of these correlations is statistically significant. The lack of significant correlation for the severity of nephropathy may reflect the relatively short duration of diabetes in the offspring of these families and the known high intrasubject variability of AERs. These data provide the first available evidence that the severity of diabetic retinopathy is influenced by familial (possibly genetic) factors and confirmatory evidence that such factors influence the development
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D.-A. Tregouet, P.-H. Groop, S. McGinn, C. Forsblom, S. Hadjadj, M. Marre, H.-H. Parving, L. Tarnow, R. Telgmann, T. Godefroy, et al. G/T Substitution in Intron 1 of the UNC13B Gene Is Associated With Increased Risk of Nephropathy in Patients With Type 1 Diabetes Diabetes, October 1, 2008; 57(10): 2843 - 2850. [Abstract] [Full Text] [PDF]

				J. J. Rogus, G. D. Poznik, M. G. Pezzolesi, A. M. Smiles, J. Dunn, W. Walker, K. Wanic, D. Moczulski, L. Canani, S. Araki, et al. High-Density Single Nucleotide Polymorphism Genome-Wide Linkage Scan for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes: Discordant Sibpair Approach Diabetes, September 1, 2008; 57(9): 2519 - 2526. [Abstract] [Full Text] [PDF]

				K. Hietala, C. Forsblom, P. Summanen, P.-H. Groop, and on behalf of the FinnDiane Study Group Heritability of Proliferative Diabetic Retinopathy Diabetes, August 1, 2008; 57(8): 2176 - 2180. [Abstract] [Full Text] [PDF]

				Z. Tong, Z. Yang, S. Patel, H. Chen, D. Gibbs, X. Yang, V. S. Hau, Y. Kaminoh, J. Harmon, E. Pearson, et al. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications PNAS, May 13, 2008; 105(19): 6998 - 7003. [Abstract] [Full Text] [PDF]

				S. K. Cordovado, Y. Zhao, J. H. Warram, H. Gong, K. L. Anderson, M. M. Hendrix, L. N. Hancock, P. A. Cleary, and P. W. Mueller Nephropathy in Type 1 Diabetes Is Diminished in Carriers of HLA-DRB1*04: The Genetics of Kidneys in Diabetes (GoKinD) Study Diabetes, February 1, 2008; 57(2): 518 - 522. [Abstract] [Full Text] [PDF]

				H. Al-Kateb, A. P. Boright, L. Mirea, X. Xie, R. Sutradhar, A. Mowjoodi, B. Bharaj, M. Liu, J. M. Bucksa, V. L. Arends, et al. Multiple Superoxide Dismutase 1/Splicing Factor Serine Alanine 15 Variants Are Associated With the Development and Progression of Diabetic Nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics Study Diabetes, January 1, 2008; 57(1): 218 - 228. [Abstract] [Full Text] [PDF]

				M. C. Monti, J. T. Lonsdale, C. Montomoli, R. Montross, E. Schlag, and D. A. Greenberg Familial Risk Factors for Microvascular Complications and Differential Male-Female Risk in a Large Cohort of American Families with Type 1 Diabetes J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4650 - 4655. [Abstract] [Full Text] [PDF]

				H. A. Keenan, T. Costacou, J. K. Sun, A. Doria, J. Cavellerano, J. Coney, T. J. Orchard, L. P. Aiello, and G. L. King Clinical Factors Associated With Resistance to Microvascular Complications in Diabetic Patients of Extreme Disease Duration: The 50-year Medalist Study Diabetes Care, August 1, 2007; 30(8): 1995 - 1997. [Full Text] [PDF]

				H. Al-Kateb, L. Mirea, X. Xie, L. Sun, M. Liu, H. Chen, S. B. Bull, A. P. Boright, A. D. Paterson, and for the DCCT/EDIC Research Group Multiple Variants in Vascular Endothelial Growth Factor (VEGFA) Are Risk Factors for Time to Severe Retinopathy in Type 1 Diabetes: The DCCT/EDIC Genetics Study Diabetes, August 1, 2007; 56(8): 2161 - 2168. [Abstract] [Full Text] [PDF]

				L. M. Thorn, C. Forsblom, J. Fagerudd, K. Pettersson-Fernholm, R. Kilpikari, P.-H. Groop, and on behalf of the FinnDiane Study Group Clustering of Risk Factors in Parents of Patients With Type 1 Diabetes and Nephropathy Diabetes Care, May 1, 2007; 30(5): 1162 - 1167. [Abstract] [Full Text] [PDF]

				H. C. Looker, R. G. Nelson, E. Chew, R. Klein, B. E.K. Klein, W. C. Knowler, and R. L. Hanson Genome-Wide Linkage Analyses to Identify Loci for Diabetic Retinopathy Diabetes, April 1, 2007; 56(4): 1160 - 1166. [Abstract] [Full Text] [PDF]

				D. M. Hallman, E. Boerwinkle, V. H. Gonzalez, B. E. K. Klein, R. Klein, and C. L. Hanis A Genome-Wide Linkage Scan for Diabetic Retinopathy Susceptibility Genes in Mexican Americans With Type 2 Diabetes From Starr County, Texas Diabetes, April 1, 2007; 56(4): 1167 - 1173. [Abstract] [Full Text] [PDF]

				N. Vionnet, D. Tregouet, G. Kazeem, I. Gut, P.-H. Groop, L. Tarnow, H.-H. Parving, S. Hadjadj, C. Forsblom, M. Farrall, et al. Analysis of 14 Candidate Genes for Diabetic Nephropathy on Chromosome 3q in European Populations: Strongest Evidence for Association With a Variant in the Promoter Region of the Adiponectin Gene Diabetes, November 1, 2006; 55(11): 3166 - 3174. [Abstract] [Full Text] [PDF]

				T. Costacou, Y. Chang, R. E. Ferrell, and T. J. Orchard Identifying Genetic Susceptibilities to Diabetes-related Complications among Individuals at Low Risk of Complications: An Application of Tree-Structured Survival Analysis Am. J. Epidemiol., November 1, 2006; 164(9): 862 - 872. [Abstract] [Full Text] [PDF]

				K. Thamotharampillai, A. K.F. Chan, B. Bennetts, M. E. Craig, J. Cusumano, M. Silink, P. J. Oates, and K. C. Donaghue Decline in Neurophysiological Function After 7 Years in an Adolescent Diabetic Cohort and the Role of Aldose Reductase Gene Polymorphisms. Diabetes Care, September 1, 2006; 29(9): 2053 - 2057. [Abstract] [Full Text] [PDF]

				P. W. Mueller, J. J. Rogus, P. A. Cleary, Y. Zhao, A. M. Smiles, M. W. Steffes, J. Bucksa, T. B. Gibson, S. K. Cordovado, A. S. Krolewski, et al. Genetics of Kidneys in Diabetes (GoKinD) Study: A Genetics Collection Available for Identifying Genetic Susceptibility Factors for Diabetic Nephropathy in Type 1 Diabetes J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1782 - 1790. [Abstract] [Full Text] [PDF]

				T Y Wong, Q Mohamed, R Klein, and D J Couper Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes? Br. J. Ophthalmol., March 1, 2006; 90(3): 301 - 303. [Abstract] [Full Text] [PDF]

				M. E. Molitch, D. Rupp, and M. Carnethon Higher Levels of HDL Cholesterol Are Associated With a Decreased Likelihood of Albuminuria in Patients With Long-Standing Type 1 Diabetes Diabetes Care, January 1, 2006; 29(1): 78 - 82. [Abstract] [Full Text] [PDF]

				P. J. Beisswenger, K. S. Drummond, R. G. Nelson, S. K. Howell, B. S. Szwergold, and M. Mauer Susceptibility to Diabetic Nephropathy Is Related to Dicarbonyl and Oxidative Stress Diabetes, November 1, 2005; 54(11): 3274 - 3281. [Abstract] [Full Text] [PDF]

				N. Yamada, Y. Horikawa, N. Oda, K. Iizuka, N. Shihara, S. Kishi, and J. Takeda Genetic Variation in the Hypoxia-Inducible Factor-1{alpha} Gene Is Associated with Type 2 Diabetes in Japanese J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5841 - 5847. [Abstract] [Full Text] [PDF]

				M. J. Taverna, J.-L. Selam, and G. Slama Association between a Protein Polymorphism in the Start Codon of the Vitamin D Receptor Gene and Severe Diabetic Retinopathy in C-Peptide-Negative Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4803 - 4808. [Abstract] [Full Text] [PDF]

				M. Rema, S. Premkumar, B. Anitha, R. Deepa, R. Pradeepa, and V. Mohan Prevalence of Diabetic Retinopathy in Urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2328 - 2333. [Abstract] [Full Text] [PDF]

				The PKC-DRS Study Group The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of the Protein Kinase C {beta} Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial Diabetes, July 1, 2005; 54(7): 2188 - 2197. [Abstract] [Full Text] [PDF]

				D. M. Hallman, J. C. Huber Jr., V. H. Gonzalez, B. E.K. Klein, R. Klein, and C. L. Hanis Familial Aggregation of Severity of Diabetic Retinopathy in Mexican Americans From Starr County, Texas Diabetes Care, May 1, 2005; 28(5): 1163 - 1168. [Abstract] [Full Text] [PDF]

				A. P. Boright, A. D. Paterson, L. Mirea, S. B. Bull, A. Mowjoodi, S. W. Scherer, B. Zinman, and and the DCCT/EDIC Research Group Genetic Variation at the ACE Gene Is Associated With Persistent Microalbuminuria and Severe Nephropathy in Type 1 Diabetes: The DCCT/EDIC Genetics Study Diabetes, April 1, 2005; 54(4): 1238 - 1244. [Abstract] [Full Text] [PDF]

				J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz Diabetic Nephropathy: Diagnosis, Prevention, and Treatment Diabetes Care, January 1, 2005; 28(1): 164 - 176. [Abstract] [Full Text] [PDF]

				S. Hadjadj, F. Pean, Y. Gallois, P. Passa, R. Aubert, L. Weekers, V. Rigalleau, B. Bauduceau, A. Bekherraz, R. Roussel, et al. Different Patterns of Insulin Resistance in Relatives of Type 1 Diabetic Patients With Retinopathy or Nephropathy: The Genesis France-Belgium Study Diabetes Care, November 1, 2004; 27(11): 2661 - 2668. [Abstract] [Full Text] [PDF]

				A. Parvanova, I. Iliev, M. Filipponi, B. D. Dimitrov, M. Vedovato, A. Tiengo, R. Trevisan, G. Remuzzi, and P. Ruggenenti Insulin Resistance and Proliferative Retinopathy: A Cross-Sectional, Case-Control Study in 115 Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4371 - 4376. [Abstract] [Full Text] [PDF]

				L Kessel, B Sander, P Dalgaard, and M Larsen Lens fluorescence and metabolic control in type 1 diabetic patients: a 14 year follow up study Br. J. Ophthalmol., September 1, 2004; 88(9): 1169 - 1172. [Abstract] [Full Text] [PDF]

				R. N. Frank Diabetic Retinopathy N. Engl. J. Med., January 1, 2004; 350(1): 48 - 58. [Full Text] [PDF]

				J. Q. Purnell, R. K. Dev, M. W. Steffes, P. A. Cleary, J. P. Palmer, I. B. Hirsch, J. E. Hokanson, and J. D. Brunzell Relationship of Family History of Type 2 Diabetes, Hypoglycemia, and Autoantibodies to Weight Gain and Lipids With Intensive and Conventional Therapy in the Diabetes Control and Complications Trial Diabetes, October 1, 2003; 52(10): 2623 - 2629. [Abstract] [Full Text] [PDF]

				R. D. G. Leslie, H. Beyan, P. Sawtell, B. O. Boehm, T. D. Spector, and H. Snieder Level of an Advanced Glycated End Product Is Genetically Determined: A Study of Normal Twins Diabetes, September 1, 2003; 52(9): 2441 - 2444. [Abstract] [Full Text] [PDF]

				M. Merta, J. Reiterova, R. Rysava, D. Kmentova, and V. Tesar Genetics of diabetic nephropathy Nephrol. Dial. Transplant., July 1, 2003; 18(90005): v24 - 25. [Abstract] [Full Text] [PDF]

				R. L. Klein, S. J. Hunter, A. J. Jenkins, D. Zheng, A. J. Semler, J. Clore, W. T. Garvey, and The DCCT/EDIC Study Group Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care, May 1, 2003; 26(5): 1439 - 1448. [Abstract] [Full Text] [PDF]

				S. Fava and A. T. Hattersley The role of genetic susceptibility in diabetic nephropathy: evidence from family studies Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1543 - 1546. [Full Text] [PDF]

				C J Schultz, R Amin, and D B Dunger Markers of microvascular complications in insulin dependent diabetes Arch. Dis. Child., July 1, 2002; 87(1): 10 - 12. [Full Text] [PDF]

				J. J. Rogus, J. H. Warram, and A. S. Krolewski Genetic Studies of Late Diabetic Complications: The Overlooked Importance of Diabetes Duration Before Complication Onset Diabetes, June 1, 2002; 51(6): 1655 - 1662. [Abstract] [Full Text] [PDF]

				W. THOMAS, Y. SHEN, M. E. MOLITCH, and M. W. STEFFES Rise in Albuminuria and Blood Pressure in Patients Who Progressed to Diabetic Nephropathy in the Diabetes Control and Complications Trial J. Am. Soc. Nephrol., February 1, 2001; 12(2): 333 - 340. [Abstract] [Full Text]

				C. Giusti, R. Schiaffini, C. Brufani, A. Pantaleo, E. M. Vingolo, and P. Gargiulo Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients Br. J. Ophthalmol., June 1, 2000; 84(6): 591 - 595. [Abstract] [Full Text]

				E. S Kilpatrick Glycated haemoglobin in the year 2000 J. Clin. Pathol., May 1, 2000; 53(5): 335 - 339. [Full Text] [PDF]

				K. M. WARPEHA, W. XU, L. LIU, I. G. CHARLES, C. C. PATTERSON, F. AH-FAT, S. HARDING, P. M. HART, U. CHAKRAVARTHY, and A. E. HUGHES Genotyping and functional analysis of a polymorphic (CCTTT)n repeat of NOS2A in diabetic retinopathy FASEB J, October 1, 1999; 13(13): 1825 - 1832. [Abstract] [Full Text]